This collaborative article reviews chronic pulmonary aspergillosis (CPA) from the perspective of a multidisciplinary team comprising of respiratory physicians, radiologists, mycologists, dietitians, pharmacists, physiotherapists and palliative care specialists. The review synthesises current knowledge on CPA, emphasising the intricate interplay between clinical, radiological, and microbiological aspects. We highlight the importance of assessing each patient as a multidisciplinary team to ensure personalised treatment strategies and a holistic approach to patient care.
Share this post
Latest News posts
Winter 2025–26: Flu & Other Respiratory Viruses. Bad Flu Season coming?
September 25, 2025
🧾 Vitamins & Minerals in Aspergillosis: What Patients Should Know
September 25, 2025
🌟 Biologics and the Future: A Toolkit for Severe Asthma, ABPA & Beyond
September 24, 2025
Steroid Use and Your Eyesight: What Patients Need to Know
September 23, 2025
Comparing Health Systems: NHS vs Insurance-Based Models
September 18, 2025
Personality, Connection, and Mental Health
September 17, 2025
Grief and the Loss of Health in Aspergillosis
September 17, 2025
News archive
× Close
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Research
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel & Insurance
- Treatment
- Vaccines
- Weekly Updates
